Latest Addiction Medicine News
In a Q&A, David Fiellin, MD, professor of medicine (general medicine), discusses harm reduction, fentanyl test strips, and the reasons behind the rise in fentanyl-related overdose deaths.
- March 15, 2024
Announcing the new 2024 residents in Yale Internal Medicine's Primary Care Residency Program.
- March 13, 2024Source: National Geographic
Yale School of Medicine's Stephen Holt, MD, associate professor of medicine (general medicine), discusses why people feel more relaxed when they drink.
- March 12, 2024
The newly announced election brings the number of AAP members from Yale to 53.
- March 02, 2024Source: NBC News
Addiction treatment can mean anything from equine therapy to the peer-supported spiritual programming of 12-step recovery groups. Of the treatment options for opioid addiction, methadone and buprenorphine have the “strongest scientific evidence,” said Dr. David Fiellin, director of the Yale Program in Addiction Medicine.
- February 16, 2024Source: WBUR
Camenga and Hadland say medical schools and pediatric residency programs are adding information to their curricula about substance use disorders, including how to discuss drug and alcohol use with children and teens.
- February 08, 2024Source: Fox 61
Yale researchers are testing an anti-vaping game in some middle schools in our state this spring, as school officials deal with increase in vaping students.
- January 30, 2024
The Infectious Disease Diversity, Equity, and Anti-Racism Committee (ID2EA) was formed in March 2020 as a joint effort by faculty from the Yale Section of Infectious Diseases, the Poorvu Center for Teaching and Learning, and faculty in Yale School of Medicine’s Section of the History of Medicine. ID2EA aims to take a multi-pronged approach towards incorporating a focus on equity and antiracism into the education and professional development initiatives within the Department of Internal Medicine’s Section of Infectious Diseases.
- January 23, 2024
Emergency departments (EDs) are essential but underutilized access points for opioid use disorder diagnosis and treatment. Harnessing electronic health record (EHR) data to drive infrastructure development and service improvement is one promising pathway toward maximizing the potential of EDs to connect individuals with opioid use disorder to care. A new clinical trial funded through the National Institutes of Health Helping End Addiction Long-term (HEAL) Data2Action Initiative proposes to do just that.
- January 19, 2024
Jeanette Tetrault, MD, FACP, FASAM, professor of medicine (general medicine), Yale School of Medicine, and chronic disease epidemiology, Yale School of Public Health, was awarded the John P. McGovern Award for Excellence in Medical Education at the Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) annual conference in November 2023.